OncoInsight

Insightful breakthrough medicine for immune cell therapy

OncoInsight was founded in 2020, is headquartered in Seoul, South Korea, lists 11–50 employees, and has $21.2M in recorded funding across 1 round.

Headquarters
Seoul
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$21.2M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

OncoInsight is a South Korean biotechnology company developing advanced allogeneic immune cell therapies for cancer treatment. The company's pipeline includes UCB-NK cell therapy for breast cancer, CAR-NK cell therapy for gastric cancer, iPSC-derived NK cells, CAR macrophage therapies for solid tumors, and HSC-derived CAR-NK cells for B cell-driven autoimmune diseases such as lupus. OncoInsight also uses humanized mice as preclinical tools for human-specific studies. The company's mission is to discover, develop, and deliver novel off-the-shelf NK cell therapy product candidates that have a profound impact on cancer patients, aiming to become the leading company in accessible cell therapies.

Summary

OncoInsight is a Biotech company based in Seoul, South Korea, founded in 2020. It lists 11–50 employees. It has raised $21.2M in total across 1 round. Investors include Envester, KB Securities and SBI Investment.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A
$21.2M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OncoInsight on Indexed.vc
<a href="https://indexed.vc/companies/oncoinsight"><img src="https://indexed.vc/api/badge/company/oncoinsight" alt="OncoInsight on Indexed.vc" width="260" height="76" /></a>